FENC Operating Cash Flow Growth
Fennec Pharmaceuticals Inc · Operating Cash Flow Growth
FENC Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported82.54%period ending
FENC TTM Cash from Operations YoY % (-68.25% → 82.54%)
Year-over-year change
High-resolution chart · PNG
FENC operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 82.5402% | |
| 64.7482% | |
| -146.2305% | |
| -133.8434% | |
| -150.7118% | |
| -159.623% | |
| 257.382% | |
| 223.6259% | |
| 207.9916% | |
| 232.2537% | |
| 5.067% | |
| -31.6116% | |
| -71.3792% | |
| -54.0897% | |
| -26.9723% | |
| -1.6829% | |
| 25.6732% | |
| 12.6563% | |
| 8.8041% | |
| -2.5897% | |
| -56.6791% | |
| -49.4579% | |
| -72.1302% | |
| -33.6635% | |
| -9.4838% | |
| -20.4243% | |
| -15.768% | |
| -67.3102% | |
| -75.139% | |
| -82.7829% | |
| -114.941% | |
| -112.0055% | |
| -121.4059% | |
| -104.0435% | |
| -71.4218% | |
| -51.3681% | |
| -32.387% | |
| -18.3736% | |
| -14.0709% | |
| -1.6264% | |
| -3.3696% | |
| -11.7309% | |
| -9.5939% | |
| -13.7232% | |
| -8.1081% | |
| 20.2659% | |
| 23.1222% | |
| 27.8208% | |
| 34.0054% | |
| 22.7418% | |
| 26.1857% | |
| 27.5281% | |
| 17.1805% | |
| -2.4311% | |
| 7.1916% | |
| -2.8902% | |
| -2.8402% | |
| -4.4335% | |
| -67.3237% | |
| -113.8736% | |
| -91.8885% | |
| 3.0848% | |
| 58.8737% | |
| 79.5678% | |
| 82.2137% | |
| 73.4626% | |
| 56.6247% | |
| 31.1231% | |
| 12.4963% | |
| -5.5876% | |
| 18.7552% | |
| 28.2975% | |
| 34.719% | |
| 41.7946% | |
| 1.2764% | |
| -5.6193% | |
| -7.8226% | |
| -29.5577% | |
| -9.9013% | |
| -329.0605% | |
| -921.0946% | |
| -1,527.5988% | |
| -1,829,134,473.6121% | |
| 54.0581% | |
| 76.4483% | |
| 86.7111% | |
| 100% | |
| -16.3062% | |
| -10.2501% | |
| -16.6223% | |
| -54.4808% | |
| -84.8139% | |
| -68.2522% |